3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
6
Gastritis, Atrophic
3
Colorectal Neoplasms
2
Tuberculosis
1
Peptic Ulcer
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Lymphatic Metastasis
1
Liver Neoplasms
1
Liver Cirrhosis
1
Influenza, Human
1
Inflammatory Bowel Diseases
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Communicable Diseases
1
Barrett Esophagus
1
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Gastroscopy
×
Clear all
NCT03228095
2018-08-21
Volatolome
University of Latvia
Unknown
3,000 enrolled